Targeting sTNF/TNFR1 Signaling as a New Therapeutic Strategy.
- Published in:
- Antibodies (2073-4468), 2015, v. 4, n. 1, p. 48, doi. 10.3390/antib4010048
- By:
- Publication type:
- Article
Works matching IS 20734468 AND DT 2015 AND VI 4 AND IP 1
Results: 5
1
2
TNFR1 and TNFR2 Expression and Induction on Human Treg Cells from Type 1 Diabetic Subjects.
- Published in:
- Antibodies (2073-4468), 2015, v. 4, n. 1, p. 34, doi. 10.3390/antib4010034
- By:
- Publication type:
- Article
3
Cell-Free Synthesis Meets Antibody Production: A Review.
- Published in:
- Antibodies (2073-4468), 2015, v. 4, n. 1, p. 12, doi. 10.3390/antib4010012
- By:
- Publication type:
- Article
4
Acknowledgement to Reviewers of Antibodies in 2014.
- Published in:
- Antibodies (2073-4468), 2015, v. 4, n. 1, p. 11, doi. 10.3390/antib4010011
- Publication type:
- Article
5
Both Tumor Necrosis Factor Receptor Signaling Pathways Contribute to Mortality but not to Splenomegaly in Generalized Lymphoproliferative Disorder.
- Published in:
- Antibodies (2073-4468), 2015, v. 4, n. 1, p. 1, doi. 10.3390/antib4010001
- By:
- Publication type:
- Article